» Articles » PMID: 32466494

Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 May 30
PMID 32466494
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Despite numerous available resources of evidence, the results about the frequency of pregnancy-associated cancer (PAC) still show poor comparability due to dissimilarities in the study design and methodology, inclusion criteria, incoherent duration of follow-up and a heterogeneous reference population. We conducted a systematic review of population-based studies on PAC published up to December 2019, to provide updated research on this topic, highlighting strengths and limitations. Of the 24 papers included, 11 considered all types of tumors and 13 dealt with specific types of cancer. Differences in the procedures for estimating the frequency of PAC emerged even among population studies. However, we found consistent results for overall frequency of PAC- around 1/1000 pregnancies. Our review suggests that about 25% of PAC cases are diagnosed during pregnancy, confirming the hypothesis of an excess of diagnosis in the postpregnancy period. Sparse and inconsistent results were found regarding a potential increase in the frequency of PAC over calendar years. Alignments in the strategy to identify PAC are needed to overcome methodological weaknesses.

Citing Articles

Diagnosis and Management of Cancers in Pregnancy: The Results of a Dual Battle Between Oncological Condition and Maternal Environment-Literature Review.

Dinu M, Sima R, Diaconescu A, Poenaru M, Gorecki G, Amza M Cancers (Basel). 2025; 17(3).

PMID: 39941758 PMC: 11815883. DOI: 10.3390/cancers17030389.


Evaluating Offspring After Pregnancy-Associated Cancer: A Systematic Review of Neonatal Outcomes.

Petca A, Niculae L, Tocariu R, Noditi A, Petca R, Rotar I Cancers (Basel). 2025; 17(2).

PMID: 39858081 PMC: 11764464. DOI: 10.3390/cancers17020299.


AI-assisted Total Body Dermoscopic Evaluation of Changes in Melanocytic Nevi during Pregnancy: A Prospective, Comparative Study of 2,799 Nevi.

Peter J, Helfenstein F, Cerminara S, Maul J, Zehnder M, Jamiolkowski D Acta Derm Venereol. 2025; 105:adv41025.

PMID: 39749388 PMC: 11697141. DOI: 10.2340/actadv.v105.41025.


Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age.

Maraschini A, Decenti E, Donati S, Francisci S, Lopez T, Amodio R Tumori. 2024; 111(1):71-78.

PMID: 39620650 PMC: 11789424. DOI: 10.1177/03008916241298810.


"I didn't really fit into any boxes": understanding the experiences of women affected by cancer in pregnancy and up to one-year postpartum-a mixed-method systematic review.

Armitage L, Atchan M, Davis D, Turner M, Paterson C J Cancer Surviv. 2024; .

PMID: 39460895 DOI: 10.1007/s11764-024-01695-z.


References
1.
Lee Y, Roberts C, Young J, Dobbins T . Using hospital discharge data to identify incident pregnancy-associated cancers: a validation study. BMC Pregnancy Childbirth. 2013; 13:37. PMC: 3598759. DOI: 10.1186/1471-2393-13-37. View

2.
Lambe M, Ekbom A . Cancers coinciding with childbearing: delayed diagnosis during pregnancy?. BMJ. 1995; 311(7020):1607-8. PMC: 2551500. DOI: 10.1136/bmj.311.7020.1607. View

3.
Andersson T, Johansson A, Hsieh C, Cnattingius S, Lambe M . Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009; 114(3):568-572. DOI: 10.1097/AOG.0b013e3181b19154. View

4.
Maor G, Czuzoj-Shulman N, Spence A, Abenhaim H . Neonatal outcomes of pregnancy-associated breast cancer: Population-based study on 11 million births. Breast J. 2018; 25(1):86-90. DOI: 10.1111/tbj.13156. View

5.
Bannister-Tyrrell M, Roberts C, Hasovits C, Nippita T, Ford J . Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994-2008. Aust N Z J Obstet Gynaecol. 2014; 55(2):116-22. DOI: 10.1111/ajo.12279. View